Maxcyte (MXCT) Asset Writedowns and Impairment (2023 - 2026)
Maxcyte (MXCT) posted quarterly Asset Writedowns and Impairment of $197000.0 for Q1 2026, up 203.08% year-over-year from $65000.0 in Q1 2025, and down 69.55% quarter-over-quarter from $647000.0 in Q4 2025.
Maxcyte (MXCT) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Asset Writedowns and Impairment for 4 consecutive years, with $197000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment rose 203.08% year-over-year to $197000.0; the TTM figure through Mar 2026 stood at $808000.0 (up 514.36% YoY), while the FY2025 annual figure was $676000.0, up 620.0% from the prior year.
- Asset Writedowns and Impairment retreated to $197000.0 in Q1 2026 per MXCT's latest filing, from $647000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $647000.0 in Q4 2025 and bottomed at -$267000.0 in Q3 2024.
- Historically, Asset Writedowns and Impairment has averaged $68400.0 across 4 years, with a median of $36000.0 in 2024.
- Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment tumbled 2866.67% — and 2025, when it surged 1328.57%.
- Maxcyte's Asset Writedowns and Impairment stood at -$50000.0 in 2023, then tumbled by 434.0% to -$267000.0 in 2024, then jumped by 342.32% to $647000.0 in 2025, then slumped by 69.55% to $197000.0 in 2026.
- Business Quant data shows MXCT's Asset Writedowns and Impairment at $197000.0 in Q1 2026, $647000.0 in Q4 2025, and -$136000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 630,000.00 |
| Jun 30, 2026 | 630,000.00 |
| Mar 31, 2026 | 197,000.00 |
| Mar 31, 2026 | 197,000.00 |
| Dec 31, 2025 | 647,000.00 |
| Dec 31, 2025 | 647,000.00 |
| Sep 30, 2025 | -136,000.00 |
| Sep 30, 2025 | -136,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Sep 30, 2024 | -267,000.00 |
| Sep 30, 2024 | -267,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Dec 31, 2023 | -50,000.00 |
| Dec 31, 2023 | -50,000.00 |